NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

NCT03848052

RecruitingN/A

Sponsor: UNICANCER

Conditions: Lung Cancer

Countries: France

This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospitals).

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion criteria :

* Adult (over 18)
* Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site

Exclusion criteria

\- None
Locations (21)
  • Angers, France
  • Bordeaux, France
  • Caen, France
  • Clermont-Ferrand, France
  • Créteil, France
  • Dijon, France
  • Lille, France
  • Lyon, France
  • Marseille, France
  • Montpellier, France
  • Mulhouse, France
  • Nantes, France
  • Nice, France
  • Paris, France
  • Reims, France
  • Rouen, France
  • Saint-Cloud, France
  • Strasbourg, France
  • Toulouse, France
  • Vandœuvre-lès-Nancy, France
  • Villejuif, France